Spineway (France) Executives
| ALSPW Stock | EUR 0.19 0.01 5.56% |
Spineway employs about 10 people. The company is managed by 8 executives with a total tenure of roughly 24 years, averaging almost 3.0 years of service per executive, having 1.25 employees per reported executive. Discussion of Spineway's management performance can provide insight into the enterprise performance.
| Stephane Roux Chairman Chairman of the Board, CEO |
Spineway |
Spineway Management Team Effectiveness
The company has return on total asset (ROA) of (0.041) % which means that it has lost $0.041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0836) %, meaning that it generated substantial loss on money invested by shareholders. Spineway's management efficiency ratios could be used to measure how well Spineway manages its routine affairs as well as how well it operates its assets and liabilities.About 99.99 % of Spineway outstanding shares are held by general public with 0.007 (%) owned by insiders and only 0.0 % by institutional holders.
Spineway Workforce Comparison
Spineway is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 306. Spineway holds roughly 10.0 in number of employees claiming about 3% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.43) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.43. Spineway Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Spineway Price Series Summation is a cross summation of Spineway price series and its benchmark/peer.
Spineway Notable Stakeholders
A Spineway stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spineway often face trade-offs trying to please all of them. Spineway's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spineway's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stephane Roux | Chairman of the Board, CEO | Profile | |
| Philippe Laurito | Director Inc | Profile | |
| David Siegrist | Financial Director | Profile | |
| Jon Luedke | CEO Inc | Profile | |
| Guillaume Bertet | Controller | Profile | |
| Agns Mignani | HR Mang | Profile | |
| MarieChristelle Desmolles | Controller | Profile | |
| Mickal Battisti | Controller | Profile |
About Spineway Management Performance
The success or failure of an entity such as Spineway often depends on how effective the management is. Spineway management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Spineway management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Spineway management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France. SPINEWAY operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 34 people.
Spineway Workforce Analysis
Traditionally, organizations such as Spineway use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spineway within its industry.Spineway Manpower Efficiency
Return on Spineway Manpower
| Revenue Per Employee | 427.2K | |
| Revenue Per Executive | 534.1K | |
| Net Loss Per Employee | 151.3K | |
| Net Loss Per Executive | 189.1K | |
| Working Capital Per Employee | 200K | |
| Working Capital Per Executive | 250K |
Additional Tools for Spineway Stock Analysis
When running Spineway's price analysis, check to measure Spineway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineway is operating at the current time. Most of Spineway's value examination focuses on studying past and present price action to predict the probability of Spineway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineway's price. Additionally, you may evaluate how the addition of Spineway to your portfolios can decrease your overall portfolio volatility.